Tivity Health Inc (TVTY) Forecasted to Post Q2 2019 Earnings of $0.67 Per Share

Tivity Health Inc (NASDAQ:TVTY) – Investment analysts at SunTrust Banks issued their Q2 2019 earnings per share estimates for shares of Tivity Health in a report released on Tuesday, May 14th. SunTrust Banks analyst D. Macdonald forecasts that the company will post earnings of $0.67 per share for the quarter. SunTrust Banks currently has a “Buy” rating and a $28.00 price target on the stock. SunTrust Banks also issued estimates for Tivity Health’s Q3 2019 earnings at $0.59 EPS, Q4 2019 earnings at $0.58 EPS, FY2019 earnings at $2.35 EPS and FY2020 earnings at $2.52 EPS.

Tivity Health (NASDAQ:TVTY) last posted its earnings results on Wednesday, May 8th. The company reported $0.51 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.01. The business had revenue of $214.10 million during the quarter, compared to the consensus estimate of $200.39 million. Tivity Health had a return on equity of 26.02% and a net margin of 12.18%. Tivity Health’s revenue was up 42.8% on a year-over-year basis. During the same quarter last year, the company earned $0.49 EPS.

Several other equities analysts also recently commented on the company. BidaskClub downgraded Tivity Health from a “hold” rating to a “sell” rating in a research report on Tuesday, March 5th. Barrington Research restated an “outperform” rating and set a $40.00 target price on shares of Tivity Health in a research report on Wednesday, February 20th. They noted that the move was a valuation call. Cantor Fitzgerald restated an “overweight” rating and set a $40.00 target price on shares of Tivity Health in a research report on Wednesday, February 20th. Piper Jaffray Companies cut their target price on Tivity Health to $29.00 and set an “overweight” rating for the company in a research report on Wednesday, February 20th. Finally, Chardan Capital restated a “buy” rating and set a $31.00 target price (down previously from $41.00) on shares of Tivity Health in a research report on Friday, February 1st. One research analyst has rated the stock with a sell rating, one has given a hold rating and nine have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $33.00.

Tivity Health stock opened at $18.90 on Friday. The company has a quick ratio of 0.71, a current ratio of 0.86 and a debt-to-equity ratio of 2.13. The company has a market cap of $900.58 million, a P/E ratio of 8.08, a P/E/G ratio of 0.77 and a beta of 1.10. Tivity Health has a one year low of $16.25 and a one year high of $41.46.

Institutional investors and hedge funds have recently modified their holdings of the business. Advisor Group Inc. raised its position in Tivity Health by 364.2% in the 4th quarter. Advisor Group Inc. now owns 1,142 shares of the company’s stock valued at $29,000 after purchasing an additional 896 shares during the last quarter. Enlightenment Research LLC acquired a new stake in shares of Tivity Health in the 4th quarter valued at $37,000. Shell Asset Management Co. acquired a new stake in shares of Tivity Health in the 1st quarter valued at $33,000. Pearl River Capital LLC acquired a new stake in shares of Tivity Health in the 1st quarter valued at $36,000. Finally, Asset Dedication LLC acquired a new stake in shares of Tivity Health in the 1st quarter valued at $46,000. Hedge funds and other institutional investors own 85.43% of the company’s stock.

In other Tivity Health news, Director Sara Finley acquired 2,000 shares of the business’s stock in a transaction on Wednesday, March 20th. The stock was purchased at an average price of $17.25 per share, for a total transaction of $34,500.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Bradley S. Karro acquired 2,900 shares of the business’s stock in a transaction on Friday, March 22nd. The stock was acquired at an average price of $16.54 per share, with a total value of $47,966.00. Following the transaction, the director now owns 24,696 shares in the company, valued at approximately $408,471.84. The disclosure for this purchase can be found here. Insiders own 1.64% of the company’s stock.

About Tivity Health

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.

Featured Article: How do taxes affect a CDs total return?

Earnings History and Estimates for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.